Anti-Human IL-8 Azide Free

Product Specifications

Catalogue N°

857.170.000 - 200µg / 200µl
857.170.005 - 500µg / 500µl

Target species

Human

Specificity

Recognises both natural and recombinant human IL-8

Clone

B-B49

Application

ELISA

Origin

Recombinant antibody from a phage display library

Immunisation

Recombinant human IL-8

Quantity

200µg or 500µg (Discovery Size also available please enquire)

Isotype

Mouse IgG1 Kappa light chain

Format

Phosphate-buffered saline. Sterile-filtered through 0.22 µm. Carrier and preservative free

Storage

Stable at +2-8°C for 12 months. For longer storage freeze aliquots.

Synonym

CXCL8

• Related products

BACKGROUND

Interleukin 8 (IL-8) or CXCL8, Monocyte-Derived Neutrophil Chemotactic Factor (MDNCF), Neutrophil Activating Factor (NAF) and NAD-P1 is a chemokine secreted by monocytes, macrophages and endothelial cells. IL-8 chemoattracts and activates neutrophils.

The predominant form of IL-8 is a 8.4kDa protein containing 72 amino acid residues, which includes five additional N-Terminal amino-acids. IL-8 contains the four conserved cysteine residues present in CXC chemokines and also contains the “ELR” motif common to CXC chemokines that binds to CXCR1 and CXCR2.

Data indicate that IL-8 may participate in the pathogenesis of rheumatoid arthritis via the induction of neutrophil-mediated cartilage damage, and psoriasis. A causative involvement of IL-8 is found within a broad range of clinico-pathological conditions : adult respiratory distress syndrome, asthma, bacterial infections, bladder cancer, graft rejection and influenza infection, due to the now known biological properties of IL-8. This cytokine especially in combinations with other neutrophil activating agents, may prove helpful in the treatment of patients suffering from granulocytopenia, severe infections against which antibiotics are not effective, and immunodeficiency caused by HIV.

Version 1 - 09.20

For research use only

Documents

• Safety Data Sheet Mab Azide Free

For any order, the purchaser acknowledges having read and accepted the terms and conditions described on the Diaclone website.